🔬SITC23 Thrilled to share new results we presented at the Society for Immunotherapy of Cancer (SITC) Congress! 🌎
Many thanks to all contributors,
CĂ©line Gongora
Corentin Richard
Romain Boidot
Tanguy Fortin
Alban Bessede
Yan WANG
Italiano Antoine
Based on these vaccine characterization and preclinical, in-ovo and ex-vivo efficiency data, STC-1010 treatment will soon be evaluated for the first time in clinical trial in advanced metastatic stage of colorectal cancer in 2024.
